At this time, Lu Zhengyang introduced their technical achievements in an orderly manner: "After more than a year of research and development, this nanorobot has finally been released. I think it is necessary to say that in addition to being a killer weapon that can be used to physically kill cancer cells, this type of nanorobot can also be used as a transport tool for carrying therapeutic drugs."

"If used as the former, this nanorobot is not mature enough and needs further improvements before clinical trials. However, we have also purchased a set of organ simulators from Huachang Technology for testing."

Lu Zhengyang is also very frank, saying everything, not fooling others or saying big things.

"At present, our experimental progress cannot destroy designated cancer cells in the cell population. Any cells around such nanorobots will be subjected to an indiscriminate 'suicide spiral attack' by it, whether good or bad."

The people present were shocked when they heard this. This nanorobot is now at a pace that is inseparable from us. Whether it is normal cells or cancer cells, they will be destroyed.

But this characteristic has made some people think other things. There are all kinds of people at the expo, so naturally there is no shortage of personnel from various intelligence agencies.

In the exhibition area where Lu Zhengyang is located, foreign intelligence personnel watched as tourists. After hearing this explanation, the first priority in his mind was - biological and chemical weapons.

The properties of this nanorobot are enough to kill people from the microscopic scale.

The two co-founders of Lu Zhengyang and Zhao Yu never thought of using the technology they studied for weaponization. They have always been committed to benefiting mankind. The company they jointly founded also belongs to the medical device industry, which shows that it can be explained.

Different positions have achieved different results, and once again interprets that technology is a double-edged sword.

Lu Zhengyang said: "The organ simulator we purchased from Huachang Technology will arrive soon. Next, our team will conduct the next stage of microbial experimental testing on it and continuously improve this nanorobot. I believe that its application will definitely bring real benefits to mankind in the future."

After the words were finished, I received a warm applause.

Ding Xian did not continue to stay in front of the stage for too long, and whispered a few times with the accompanying secretary assistant. After about ten minutes, he left the stage and went to the backstage of Hongrui Medical Booth to meet Lu Zhengyang.

When he arrived backstage, Ding Xiancai unexpectedly discovered that besides him, there were many fellow VCs who arrived first before him, and nodded with each other with smiles.

But Ding Xian knew that on the surface, they nodded and smiled at each other, and most of them were scolding each other in their hearts.

In the next half hour, Lu Zhengyang met and negotiated with several major VCs who came to visit. Hongrui Medical was only about three years old, but it had completed its B round of financing before, and without exception, they were all invested by Costa Øça and Shengfeng Capital, and did not accept other venture capital institutions.

Because the agreement between Hongrui Medical and Coast Blue and Shengfeng Capital is that if the company wants to conduct external financing, Coast Blue and Shengfeng Capital have priority and exclusive investment. Unless the priority and exclusive investment are waived, other VC institutions will not be able to get on Hongrui's car.

Therefore, the previous financing was paid by Luo Sheng's institutions, and other VC institutions were helpless, but they had no choice.

However, these VC institutions have been watching, and they have already received news in the next round of C financing that Luo Sheng is going to put other VCs on the bus. This is not an isolated case. Many strategic investment departments of the Costa del Sur, Shengfeng Capital is interested in potential investment projects. The C round was used to be single, and they have been sharing them since the C round.

Doing this ensures that you can eat the largest piece of cake, and at the same time, you can also get rich together. Of course, you may fail in investment, so take risks together.

However, most investment institutions are very enthusiastic, because Luo Sheng has almost no precedent for failure. As long as he let go, VCs will spend money without hesitation. Because with Luo Sheng on this table, everyone is very down-to-earth. Even if they can't understand the model and future of a company, as long as Luo Sheng is in the car, VCs don't think much about it. They just close their eyes and do it. With Mr. Luo, they can basically eat a bite of meat.

After about an hour, Ding Xian left here and was quite satisfied when he came out of the backstage because he successfully got on the car.

Hongrui Medical's C round of financing was successfully discussed within this hour. There are 6 venture capital institutions participating in this round of financing, led by Shengfeng Capital. The total round of financing is US$75 million, which is approximately RMB 500 million.

After the C round of financing, Hongrui Medical's valuation was US$1.15 billion. This valuation given by the capital market means that another unicorn-level startup technology company has been born in the technology industry.

Once this nanorobot developed by Hongrui Medical has made a major breakthrough, the future prospects are endless room for imagination.

Although it seems that it is still far from the day of success, the technological progress made by Lu Zhengyang's team is visible, which gives investors great confidence, willing to take greater risks, give Hongrui Medical a higher valuation, and expects it to thrive.

...

Costa 1st CEO's Office.

Luo Sheng stood near the window of the office and silently overlooked the expo venue below. The location of his office has a very good view. Standing next to the floor-to-ceiling window, the expo venue is unobstructed.

Today is the second day of the exhibition, with people gathering below, bustling and bustling.

At this time, someone knocked on the office door a few times.

"Come in."

Luo Sheng turned around and saw Yao Jianhong walking in.

"The leaders of the China Securities Regulatory Commission have left?" Luo Sheng came over in front of the floor-to-ceiling window and sat down on the sofa in the office's lounge area.

Yao Jianhong, who was sitting opposite him, nodded: "Well, I'm leaving, basically the agreement has been made."

The leaders of the China Securities Regulatory Commission came to the Costa del A personally for the purpose of Da A's work next year - the opening of the Science and Technology Innovation Board.

The Science and Technology Innovation Board is to establish a new sector independent of the existing main board market of Big A, and to carry out a pilot registration system within this sector.

There is no doubt that this is a very important new sector, and the country attaches great importance to it, and its market positioning is innovation-driven and the strategy of building a strong country in science and technology.

If the Science and Technology Innovation Board wants to open, a group of high-quality innovative companies will definitely need to enter the Science and Technology Innovation Board. The newly launched companies that can be called brand names are basically the Costa delle system.

It's really a lot of things to grab.

If the Science and Technology Innovation Board does not have technology companies like the Costa del Azure, it will not be representative.

In fact, the China Securities Regulatory Commission has repeatedly studied whether the Costa del Azure company can be listed on the Science and Technology Innovation Board, and chose to give up after research.

First, whether the Costa delle of the Blue or not has to lobby Luo Sheng, and the China Securities Regulatory Commission also knows that Luo Sheng will not let the company go public, including Huawei, because it is really not short of money at all and does not require margin financing and securities lending.

Another reason that cannot be ignored is equally important. With the current size of the Costa del Sur, it would be amazing.

The entire sector must be broken by this big guy. If the Costa delle goes public, there is no need to think about it, its valuation must start at 20 trillion yuan, and regardless of exchange rate changes, it starts at 3 trillion US dollars.

The entire A-share market has to be drained by this company. Maybe it may not be able to recover in two or three years, so the China Securities Regulatory Commission gave up.

The big A motherboard already has the super giant, Azule Pure Electric Automobile Company, with a current market value of 11.47 trillion yuan.

The conclusion is that Big A is not enough to carry two super giants at the same time.

However, the opening of the Science and Technology Innovation Board has been set, but the outside world does not know about this matter yet. The specific opening time has not been announced yet. Only a very small number of institutions have received notice, and the Costa delle is one of them.

Obviously, the opening of the Science and Technology Innovation Board cannot be without high-quality stocks, and it must be opened beautifully.

"The first batch of listed companies on the Science and Technology Innovation Board is set to 28. The CSRC hopes that we can provide 10 high-quality stocks as weight stocks to open the market on the Science and Technology Innovation Board. This is a batch selected from the major subsidiaries and holding companies under the Costa delta, a total of 35 companies. Mr. Luo, please take a look."

Yao Jianhong put the documents he brought on the table and pushed them in front of Luo Sheng. The latter opened the list above.

Lao Yao has selected 35 companies, but the 10 companies that were finally confirmed to be listed on the Science and Technology Innovation Board were handed over to Luo Sheng to make a decision.

The first to be affected is Xiongxin Electronics, the largest chip wafer foundry manufacturer in China, and it is also the highest valuation among the first 28 listed companies on the Science and Technology Innovation Board. The valuation given is 1.45 trillion yuan, which is approximately US$215 billion in exchange rate changes. This valuation is only less than US$20 billion different from the current market value of the performance leader Kuaiji Electric.

Once Xiongxin Electronics is on the Science and Technology Innovation Board, it will become an absolute leading stock without any suspense and will be far ahead of other listed companies in the Science and Technology Innovation Board.

Even in the entire Big A, its market value ranking is fifth, and the newly opened Science and Technology Innovation Board does require such a decisive force, which is a perfect responsibility.

"Xiongxin Electronics...well."

Luo Sheng looked at it for a while and then took a pen to check the list of the company, which means that he agreed to Xiongxin Electronics to open the market on the Science and Technology Innovation Board, and it is undoubtedly the first stock in this sector.

The second one is Jingchuang Technology, the startup company with the most potential for EDA software development in China, with a valuation of 57 billion yuan.

The third company is engaged in the field of medical devices. Huachang Technology, founded by Cao Junhui, which focuses on the development of organ simulators, has now achieved profitability and has business dealings with major biomedical research and development giants around the world. The valuation given is 320 billion yuan.

The fourth company is Bochuang Technology, which develops human-body bionic prosthetic limbs. The company founded by Chen Xin, a post-90s generation, also achieved profitability, with a valuation of 178 billion yuan.

"These 10 companies will be reported to the China Securities Regulatory Commission."

About ten minutes later, Luo Sheng selected 10 of the 35 companies selected by Lao Yao and returned the documents to him after logging on to the Science and Technology Innovation Board.

"Okay, I'll deal with it now." Yao Jianhong took back the documents and left Luo Sheng's office.

There is no doubt that these 10 companies that are about to list on the Science and Technology Innovation Board are the best targets for value investment and are definitely the most favored stocks for valuation.

The industries in which these 10 companies are chip semiconductors and medical devices. What we can see is that the trend of the technology and medical industry in 2019 next year will surely usher in a sector bull market. It is a foregone conclusion.

...
Chapter completed!